Hello, welcome to Tosun!
会员中心

Product introduction：

First intravenous and intramuscular specific cyclooxygenase-2 (COX-2) inhibitor can be used for the short-term treatment of postoperative pain, as well as for the treatment of moderate or severe postoperative acute pain in the world.
市场价：

Contact
  • Product information
  • 产品描述
  • 参数配置


1、 Product introduction

Chinese Name

English Name

Declaration Type

Department

Reportable Dosage Form

Declaration Progress

Strength

CAS
帕瑞昔布钠PARECOXIB SODIUM5+4Analgesics Freeze dried powder 

Preparing for declaration

20mg、40mg198470-85-8

【Indication】

    Analgesics 


【Reportable Dosage Form &Strength】
       Freeze dried powder :20mg、40mg


【Declaration Progress】
         Preparing for declaration



2、Domestic Declaration


Declaration Type

Reportable Dosage Form

Number of Declared Preparations

Number of Existing Preparation Enterprises

5+4冻干粉

22 domestic declaration enterprises

1 import enterprise.




 Brinzolamide 布林佐胺 CAS号：138890-62-7

Guangzhou Tosun Pharmaceutical Ltd

FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663

Tel: +86-20-66392521； Fax: +86-20-66392525

First intravenous and intramuscular specific cyclooxygenase-2 (COX-2) inhibitor can be used for the short-term treatment of postoperative pain, as well as for the treatment of moderate or severe postoperative acute pain in the world.

The world's first intravenous drug and intramuscular injection 
热门关键词： 进口原料药代理 印度进口原料药 原料药关联审评 进口药品注册代理 国内参比制剂 美国参比制剂 原料药注册服务 原料药联合申报 原料药供应商
Copyright ©2020 Guangzhou Tosun Pharmaceutical Ltd 粤ICP备16102594号-2
Maps｜ XML Maps｜   Maps
Phone

(86)18922121079

(86)18026299762

Email

tosun-global@upharm.cn

Skype

tosun-global@upharm.cn

TOP